Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus

被引：0
|
作者：
Hanne Haahr
Thomas R. Pieber
Chantal Mathieu
Theis Gondolf
Masanari Shiramoto
Lars Erichsen
Tim Heise
机构：
[1] Novo Nordisk A/S,Department of Internal Medicine
[2] Medical University of Graz,Clinical and Experimental Endocrinology, University Hospital Leuven
[3] KU Leuven,undefined
[4] SOUSEIKAI,undefined
[5] Hakata Clinic,undefined
[6] Profil,undefined
来源：
Clinical Pharmacokinetics | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：639 / 649
页数：10
相关论文
共 50 条
  • [1] Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
    Haahr, Hanne
    Pieber, Thomas R.
    Mathieu, Chantal
    Gondolf, Theis
    Shiramoto, Masanari
    Erichsen, Lars
    Heise, Tim
    CLINICAL PHARMACOKINETICS, 2019, 58 (05) : 639 - 649
  • [2] Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart versus insulin aspart in subjects with type 1 diabetes
    Twigg, Stephen
    Philis-Tsimikas, Athena
    Bode, Bruce
    Franek, Edward
    Rose, Ludger
    Buchholtz, Kristine
    Demissie, Marek
    Pieber, Thomas R.
    CLINICAL ENDOCRINOLOGY, 2018, 89 : 64 - 64
  • [3] Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart versus insulin aspart in subjects with type 1 diabetes
    Philis-Tsimikas, A.
    Bode, B. W.
    Franek, E.
    Rose, L.
    Buchholtz, K.
    Demissie, M.
    Pieber, T. R.
    DIABETOLOGIA, 2017, 60 : S315 - S315
  • [4] The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes
    Biester, Torben
    von Dem Berge, Thekla
    Bendtsen, Line Quist
    Bendtsen, Mette Dahl
    Rathor, Naveen
    Danne, Thomas
    Haahr, Hanne
    PEDIATRIC DIABETES, 2020, 21 (05) : 781 - 790
  • [5] Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis
    Dutta, Deep
    Mohindra, Ritin
    Mahajan, Kunal
    Sharma, Meha
    DIABETES & METABOLISM JOURNAL, 2023, 47 (01) : 72 - 81
  • [6] Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan
    Kawamura, Tomoyuki
    Kikuchi, Toru
    Horio, Hiroshi
    Rathor, Naveen
    Ekelund, Magnus
    ENDOCRINE JOURNAL, 2021, 68 (04) : 409 - 420
  • [7] Hypoglycaemia with mealtime fast-acting insulin aspart versus insulin aspart across two large type 1 diabetes trials
    De Block, C.
    Carlson, A.
    Rose, L.
    Gondolf, T.
    Gorst-Rasmussen, A.
    Boesgaard, T. W.
    Lane, W.
    DIABETOLOGIA, 2018, 61 : S31 - S32
  • [8] Fast-Acting Insulin aspart (faster aspart) - Clinical Data on Application in Type 1 and 2 Diabetes
    Jaeckel, E.
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (06): : 313 - 319
  • [9] Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart vs insulin aspart in subjects with Type 1 diabetes
    Leelarathna, L.
    Philis-Tsimikas, A.
    Bode, B. W.
    Franek, E.
    Rose, L.
    Buchholtz, K.
    Pieber, T. R.
    DIABETIC MEDICINE, 2018, 35 : 19 - 19
  • [10] Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes
    Bowering, K.
    Harvey, J.
    Kolaczynski, J. W.
    Snyder, J. W.
    Bode, B. W.
    DIABETIC MEDICINE, 2019, 36 (06) : 771 - 775
12345